MAP1LC3B and neoplasm: We found that protein levels of MAP1LC3B (4.41 ± 2.18 vs. 5.14 ± 1.84, p = 0.001, Table 1) and SQSTM1 (0.51 ± 1.16 vs. 3.84 ± 2.24, p <0.001, Table 1) were higher in the tumor tissue than in the CTAN tissues of IDC patients (Figure 1B,C).